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ABSTRACT 
 
DOMENICK GABRIEL GRASSO:  Mechanistic and Bioinformatic Studies of 
Mitochondrial Ribosomes and Auxiliary Translational Factors 
(Under the direction of Dr. Linda L. Spremulli) 
 
 
This body of work is focused on mitochondrial translational systems.  This apparatus 
synthesizes vital components of the electron transport chain facilitating the production of 
energy in eukaryotic cells.  Of particular interest is the role of mammalian mitochondrial 
initiation factor 2 (IF2mt) in this process.  This factor recruits the initiatior fMet-tRNA to 
begin protein synthesis within this organelle.  IF2mt is unique in that it possesses an 
insertion.  The work described here demonstrates that the insertion acts as the factor 
equivalent of initiation factor 1 (IF1).  IF1 is an essential gene in prokaryotes and eukaryotes 
(eIF1A) but has yet to be discovered in mitochondria.  IF2mt is a GTPase and the guanine 
ring binding region in this factor was probed to determine the effect of mutations on the X 
residue of the guanine ring binding motif NKXD.   Quite surprisingly despite the connotation 
of X being random, this residue is very sensitive to perturbation. 
Other work included in this dissertation includes a bioinformatics analysis of the 
proteins found in a Leishmania tarentolae mitochondrial ribosomal small subunit particle.  L. 
tarentolae is a member of the trypanosomitids family, whose members are known to cause 
African sleeping sickness and South American Chagas disease.  Examination of this organism 
offers a deeper understanding to the mechanism of action of these disease causing organisms and 
offers the potential development of therapies for these illnesses.  This study explored the 
limitations of “hits” produced by search algorithms as well as insight into mitochondrial 
ribosomal protein evolution. 
This last chapter of this dissertation attempts to further the understanding of the 
mechanisms of translation in the mammalian mitochondria by probing for previously 
unknown translational factors.  Multiple approaches are employed to find these factors 
including alignments to factors known to be involved in the prokaryotic translational 
apparatus, such as LepA, as well as promoter and import sequence analysis. 
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CHAPTER I 
 
MECHANISM OF PROTEIN SYNTHESIS 
 
 2 
 INTRODUCTION 
 
Protein synthesis is a vital part of the cellular machinery.  This process was initially 
investigated in the 1960s.  Subsequent work has revealed a diverse array of protein synthesis 
components across organisms and organelles.  The ribosome is the central player in protein 
synthesis and it acts as a scaffold which facilitates the interaction of the messenger 
ribonucleic acids (mRNA), containing the coded gene sequence, and the transfer ribonucleic 
acids  (tRNA), which carry each amino acid to the correct position in the growing 
polypeptide.  The ribosome catalyzes peptide bond formation using the peptidyltransferase 
activity of this particle.  All ribosomes are made up of a large subunit (LSU) and small 
subunit (SSU) and the chemistry of protein synthesis (translation) occurs at the interface of 
these subunits.  The small subunit cradles the mRNA and, therefore, has discrete binding 
sites for the tRNA, which complements the mRNA’s codons.  These sites are referred to as 
the acceptor-site (A-site), peptidyl-tRNA-site (P-site) and the exit-site (E-site) (Fig. 1-
1A).  The roles of these sites will be discussed later.  The large subunit contains the exit 
tunnel for the growing polypeptide chain and the site of peptidyltransferase activity (Fig. 1-
1B).  The general outline of the process involves four main steps:  initiation, elongation, 
termination and recycling.  In each step there are respective factors that allow the ribosome to 
complete its task.  These processes are carried out on the ribosome in very specific sites on 
the ribosome.  
Initiation of protein synthesis involves initiation factors (IF) that work together to 
bring the ribosome, the mRNA and the first tRNA to be positioned correctly to start 
translating the mRNA into protein.  Once the ribosome has been correctly oriented into its  
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initiation state, the elongation factors (EF) are recruited to continue the process of protein 
synthesis.  These EFs work together bringing in new aminoacyl-tRNAs (aa-tRNAs) and 
moving the mRNA through the ribosome.  There comes a point when the ribosome 
encounters a stop codon and termination needs to occur.  A release factor (RF) is involved in 
the recognition of termination codons and in the release of the growing polypeptide from the 
ribosome.  Finally the ribosomes are recycled, in most cases, by the ribosome recycling 
factor (RRF) which further dissociates the mRNA and tRNA from the ribosome and leaves it 
ready for another round of initiation.  
Of course, this simplistic view hides the grace and choreography involved in these 
processes.  Ribosomes and the processes by which proteins are made vary quite dramatically 
between organisms and even within organelles in the same cell, namely mitochondria in 
eukaryotes.  
 
PROKARYOTIC PROTEIN SYNTHESIS 
 
The protein synthesis machinery in prokaryotes is the most thoroughly understood of the 
known translational systems.  The ribosome is composed of both ribosomal RNA (rRNA) 
and proteins.  The prokaryotic ribosome is comprised of two subunits, the LSU and the small 
SSU.  The prokaryotic LSU is a 50S particle, based on its sedimentation in a sucrose 
gradient, with 33 proteins that decorate the 23S and 5S rRNAs.  The prokaryotic SSU is a 
30S particle with 21 proteins and a 16S rRNA.  These two subunits come together to form a 
70S particle. 
 5 
Translation initiation in prokaryotes involves three initiation factors:  IF1, IF2 and 
IF3.  IF1 is thought to bind at the A-site of the SSU thus preventing the initiator tRNA from 
binding [1-3] and has been implicated as an RNA chaperone [4].  IF2 is a GTPase that 
facilitates the binding of the initiator tRNA, formylmethionyl-tRNAi
Met
 (fMet- tRNAi
Met
), to 
the P-site of the SSU [5].  IF3 appears to have many functions [6]: it binds to the 30S 
ribosomal subunit thereby shifting the equilibrium of the 70S particle toward dissociation, it 
promotes 30S initiation complex formation by increasing the rate of the P-site codon-
anticodon interaction between fMet-tRNAi
Met
 and the mRNA, and it acts as a proofreading 
factor by increasing the dissociation rate of noncanonical and pseudo-30S initiation 
complexes.  The mRNA is recruited to the SSU via a base-pairing interaction between the 3' 
end of the 16S rRNA and the Shine-Dalgarno sequence located upstream of the initiation 
codon in the mRNA.  In addition single stranded regions, U-rich or U(C)/A-rich, regions of 
mRNA, interact with the ribosomal protein S1 promoting initiation on certain mRNAs [7]. 
The proposed mechanism of initiation is shown in Figure 1-2.  This process begins 
with the dissociation of the 70S particles into 50S and 30S subunits.  IF3 is thought to act as 
an antiassociation factor, binding to the 30S subunit and sequestering it for initiation.  IF1 
binds to the IF3:30S complex.  IF2 is recruited to the small subunit along with the mRNA 
and fMet- tRNAi
Met
.  IF2 interacts with the initiator tRNA and promotes the binding to the P-
site, where the initiation codon is located.  The order of binding may be random with stable 
interactions observed only when all three components are present together.  IF3 is thought to 
play a proofreading role in this process and positions the message so that the start, AUG, 
codon is correctly placed in the P-site of the ribosome.  The 50S subunit associates with this  
 6 
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complex and IF2 hydrolyzes GTP and is released along with all of the other IFs and 
translational elongation is ready to begin.  Details on the release of the initiation factors are 
not yet resolved.   
Elongation of protein synthesis immediately follows initiation.  This process (Fig. 1-
3) involves two GTPase factors, EF-Tu, which binds aminoacylated-tRNAs (aa-tRNAs), and 
EF-G, which translocates the ribosome along the mRNA exposing the next codon.  With the 
initiator tRNA in the P-site, the EF-Tu:GTP:aa-tRNA ternary complex delivers the aa-tRNA 
specific by the next codon into the A-site of the ribosome.  Once correct positioning of this 
tRNA is accomplished, EF-Tu hydrolzes GTP and is released.  The accommodation of an 
incorrect tRNA is sensed by the ribosome-bound complex and that aa-tRNA is rejected.   
The peptidyltransferase activity of the 50S subunit then catalyzes the transfer the 
peptide from the P-site peptidyl-tRNA to the amino acid on the A-site aa-tRNA resulting in a 
growing polypeptide chain.  Following this transfer, EF-G:GTP is recruited into the A-site of 
the ribosome, hydrolyzes GTP and translocates the tRNAs from the P- and A-sites to the E- 
and P-sites, respectively.  The EF-G:GDP protein is then released.  The ribosome is then 
ready for the next round of elongation.  The E-site tRNA is then ejected and EF-Tu brings in 
the aa-tRNA corresponding to the next codon on the mRNA and the process repeats itself as 
the polypeptide chain grows.    
When the translational elongation machinery reaches a stop codon (UAA, UGA, 
UGG) termination is triggered.  An overview of termination and recycling is shown in Figure 
1-4.  Termination involves three main release factors:  RF1, RF2 and RF3.  RF1 and RF2, are 
class 1 release factors which interact with the termination codons in a sequence specific  
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way.  RF1 and RF2 can both interact with UAA codons but only RF1 can decode UAG and 
only RF2 can decode UGA [8].  Once a stop codon is encountered the appropriate release 
factor RF1 or RF2 is recruited to the A-site aids in the hydrolysis of the peptidyl-tRNA.  The 
polypeptide is released and RF3 is recruited to the complex.  RF3 is the class 2 release factor 
and a GTPase, which is recruited to and stimulates the activities of RF1 and RF2 and also 
facilitates the release of the growing polypeptide from the tRNA in the P-site and prepares 
the ribosome for recycling [9].  RF3 is subsequently released and the ribosomal complex is 
ready for recycling.   
Recycling is very closely associated with termination and is facilitated by ribosome 
recycling factor (RRF), EF-G and IF3 which dissociate the 70S ribosomal complexes into the 
substituent subunits and free the mRNA and other factors interacting with the ribosome 
[10].  RRF and EF-G bind to the terminated ribosomal complex and promoted the 
dissociation of the subunits.  It is then proposed that IF3 aids in the dissociation of the 
mRNA and tRNA from the small subunit.  However there is some controversy in the role of 
IF3 in this process.  The consensus is that IF3 helps the ribosome-recycling process primarily 
by converting transiently dissociated subunits into subunits by binding sequestering the 30S 
subunits [11].  Following recycling the ribosomes are ready for another round of initiation.  
   
EUKARYOTIC PROTEIN SYNTHESIS  
   
Like prokaryotic protein synthesis, eukaryotic protein synthesis requires a unique set of 
protein factors and has a very specialized set of auxiliary components.  The most studied 
eukaryotic translational system is that of yeast.  The yeast ribosomes is an 80S particle and 
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contain a 60S LSU and a 40S SSU.  The LSU is made up of 3 rRNAs (5.8S, 25S, 5S) and 46 
ribosomal proteins.  The SSU is composed of a single 18S rRNA and 32 ribosomal proteins.   
Initiation of protein synthesis in eukaryotes, as in prokaryotes, begins with the 
binding of the mRNA and initiator tRNA to the SSU (Fig. 1-5).  In this system, eIF3 acts as 
an antiassociation factor sequestering the 40S SSU in concert with a variety of other factors 
including eIF1, eIF1A and eIF3.  These proteins interact with each other along with 
the eIF2B:GTP:fMet-tRNA
fMet
 and mRNA to form the initiation complex.  Many of these 
additional proteins are involved in the recognition of the 5' cap of the mRNA and the poly(A) 
tail a mechanism of initiation which is not known to exist in prokaryotes.  These proteins 
include eIF3, eIF4A, eIF4B, eIF4F and PAB (poly-A binding protein).  Once the mRNA is 
recruited a 43S:mRNA complex is created.  Scanning by this complex to locate the initiation 
codon, AUG, is facilitated by eIF1 and eIF1A.   Subsequently, eIF5 aids in releasing eIF2, 
which occurs following the hydrolysis of GTP.  The 60S LSU is recruited with the aid of 
eIF5B to form the 80S initiation complex. 
In contrast to initiation, the mechanism of elongation is thought to be significantly 
conserved across all kingdoms of life [12-14].  An exception in eukaryotic elongation (Fig. 1-
6) is the presence of a third elongation factor, eEF-3, which is present in fungal systems [15].  
The cognate aa-tRNA is brought into the A-site by eEF1A:GTP.  GTP is hydrolyzed and 
eEF1A is released.  The peptidyltransferase activity of the ribosome transfers the growing 
polypeptide to the A-site aa-tRNA.  Then eEF2:GTP then translocates the peptidyl-tRNAs to 
provide an open A-site for the next aa-tRNA. 
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Eukaryotic termination is also related to the process in prokaryotes (Fig. 1-6).  
However, it functions with a single class 1 release factor (eRF1) which decodes all of the 
three stop codons UAA, UAG, and UGA [16;17].  The factor eRF1 facilitates the hydrolysis 
of the peptidyl-tRNA and thus the release of the polypeptide.  Eukaryotes also contain a 
single class 2 release factor (eRF3) which, unlike prokaryotic termination factors, associates 
with eRF1 in the absence of the ribosome [18]. 
The factors involved in ribosome recycling in eukaryotes are unknown.  There does 
not appear to be an RRF ortholog in the eukaryotic genome.  Various initiation factors in 
eukaryotes have antiassociation activity in vitro but it is not known if they are relevant to 
ribosome recycling and instead used to prevent premature association of the subunits during 
initiation {5624). 
 
MITOCHONDRIAL PROTEIN SYNTHESIS  
 
Mammalian mitochondria contain their own genome, which encodes 2 rRNAs, 22 tRNAs 
and 13 proteins (Fig. 1-7) {3298}.  The 13 proteins encoded in the mitochondrial genome are 
vital components of the electron transport chain and ATP synthases, which generate over 90 
% of cellular energy.  These proteins are synthesized inside the mitochondria and are inserted 
into the inner membrane.  Hence, their synthesis require a unique mitochondrial translational 
apparatus.  The mitochondrial ribosome is a 55S complex with a 39S LSU and as 28S SSU 
[19].  The LSU contains a 16S rRNA and 48 proteins.  The SSU contains a 12S rRNA and 29 
proteins.  The mechanism of protein synthesis in mitochondria is thought to be similar to the 
prokaryotic system.  A comparison of these systems is provided in Table 1-1. 
 15 
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The initiation of protein synthesis in mitochondria is thought to be comparable to that 
of prokaryotes except that no mammalian mitochondrial IF1 homolog has been discovered 
(Table 1-2).  Initiation factor 2 (IF2mt) and initiation factor 3 (IF3mt) were discovered and 
their functions in in vitro assays were confirmed [20-22].  IF2mt selects the initiator tRNA 
and promotes its binding to the ribosome. IF3mt promotes the dissociation of the 55S 
mitochondrial ribosome into subunits and may play additional, less-well-understood, roles in 
initiation complex formation.  Despite the lack of an IF1 homolog in mitochondria there is an 
insertion in IF2mt that is proposed to play the role of IF1 as discussed in greater detail in 
Chapter III.  Significantly there are no known 5' or 3' untranslated regions (UTR) or 5' caps 
on mammalian mitochondrial mRNAs and it is not known how the mitochondrial mRNAs 
are positioned for initiation [23].  
Mitochondria contain all of the factors known to be required for elongation in 
prokaryotes; therefore, the basic steps in the process are, proposed to proceed via the same 
mechanisms.  Mitochondrial EF-Tu and EF-Ts were discovered and assayed for their relative 
activities [24-26].  Furthermore mitochondrial EF-G has also been characterized and is 
proposed to play the same role in translocation as the bacterial factor in protein synthesis 
[27].  A unique problem in the mitochondrial system is the diverse structures of the tRNAs, 
some of which lack entire loops which are strongly conserved across all kingdoms.  The 
mitochondrial EF-Tu has to overcome these deficiencies and still deliver the appropriate aa-
tRNA to the proper codon. 
Mitochondrial termination and recycling have not been explicitly studied but two 
factors homologous to the prokaryotic factors RF1 and RRF have been detected in silico and 
 18 
mitochondrial RRF (RRFmt) was cloned and expressed in E. coli [28].  No homologs of the 
bacterial RF2 and RF3 have yet been discovered in mitochondria. 
 19 
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CHAPTER II 
 
STRUCTURAL AND BIOINFORMATIC STUDIES OF MITOCHONDRIAL 
RIBOSOMES 
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INTRODUCTION 
 
Mitochondrial ribosomes differ quite significantly then their cytoplasmic counterparts.  The 
relative size and shape of ribosomes have many similarities, but the protein to ribosomal 
RNA (rRNA) content is quite variable.  The primary architecture of the ribosomal machinery 
remains the same with a large subunit (LSU) and a small subunit (SSU).  Mitochondrial 
ribosomes have been imaged using cryo-electronmicroscopy (cryoEM) and scanning electron 
microscopy (SEM) but, as of yet, none has been crystallized.  To do a thorough analysis of 
mitochondrial ribosomes one needs to compare it to the benchmark structure, the crystal 
structure of the 70S Thermus thermophilus ribosome.  To understand ribosomes from 
different sources, it is important to identify the rRNA and protein composition.  Identification 
of the rRNAs is generally straight forward due to the significant conservation of their 
structures.  However, the identification of the spectrum of ribosomal proteins present requires 
a more labor intense approach.  A proteomics and bioinformatics approach to analyze the 
protein composition of mitochondrial ribosomes has been carried out on Bos taurus and 
Leishmania tarentolae ribosomes. 
 
Prokaryotic Ribosomes 
 
As previously stated the prokaryotic ribosome is the benchmark that other ribosomes are 
compared.  This ribosome consists of a 70S particle with two distinct subunits, the 30S SSU 
and the 50S LSU.  Generally speaking the prokaryotic ribosome is rRNA decorated with 
some ribosomal proteins.  By weight, the prokaryotic ribosome is 2/3 rRNA and 1/3 
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ribosomal proteins and has a total mass 2.3 MDa.  The hallmark structural features of this 
ribosome include the head, neck, shoulder, spur and platform of the 30S SSU.  In the 50S 
LSU the L1 stalk, central protuberance and the L7/L12 stalk have been defined (Fig. 2-1) 
[1;2]. 
The 70S ribosome contains 3 rRNAs.  The 23S and the 5S rRNAs are found in the 
LSU and the 16S rRNA is found in the SSU [3] (Fig. 2-2).  These rRNAs form a complex 
secondary and tertiary structure composed of many distinct helices.  The 23S rRNA in the 
LSU contains 101 helices organized into 5 domains, of which domain V is the site of 
peptidyl transferase center (PTC).  The 5S rRNA in the LSU contains 5 helices [4].  In the 
SSU the 16S rRNA contains 45 helices which are organized into 4 domains: the 5' domain, 
the central domain, the 3' major domain and the 3' minor domain.  The 3' minor domain 
contains helix 44 in which nucleotides A1492 and A1493 reside.  These nucleotides “flip 
out” to inspect that codon:anticodon interaction of the tRNA:mRNA complex in the A-site 
and result in structural rearrangements of the rRNA.  These nucleotides also rearrange upon 
the binding of IF1 and the tRNAs [1].  The 16S rRNA in the SSU also contains the 
complementary Shine-Dalgarno sequence which facilitates positioning of the mRNA for the 
initiation of translation. 
 The ribosomal proteins bind to the rRNA scaffold.  There are a total of 54 proteins in 
the 70S complex.  The 30S SSU has 21 proteins and the 50S LSU has 33.  The locations of 
nearly all of the ribosomal proteins have been mapped.  The intersubunit space is primarily 
mediated by rRNA:rRNA interactions.  One protein occupies the intersubunit space, SSU 
protein S12.  Other notable proteins in the ribosome complex is are L7/L12 stalk, which has 
been implicated in the ribosome's GTP hydrolysis function, and is spatially close to the  
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sarcin/ricin loop (SRL) on the 23S LSU rRNA.  The 50S large subunit contains the 
peptidyltransferase center and the peptide exit channel. 
 
Mammalian Mitochondrial Ribosomes 
 
Mammalian mitochondrial ribosomes are 55S particles, consisting of a 28S SSU and a 39S 
LSU.  The composition of the mitochondrial ribosome is very different than that of the 
prokaryotic ribosome.  These ribosomes are composed of approximately 2/3 protein and 1/3 
RNA, which is the opposite of the ratio found in prokaryotes.  The mass of the mitochondrial 
55S ribosomal particle is 2.7 MDa, which is slightly more than the prokaryotic ribosome.  
Despite the greater mass, the mitochondrial ribosome has a lower sedimentation coefficient 
which suggests that it is "fluffier" (i.e. more porous) than the prokaryotic ribosome (Fig. 2-
3A) [5].  Mitochondrial ribosomes also contain the hallmark structural features found in the 
prokaryotic ribosomes.  The 28S SSU clearly has the characteristic head, neck, shoulder, spur 
and platform (Fig. 2-3B).  The 39S LSU also contains the L1 stalk, central protuberance and 
the L7/L12 stalk as previously defined (Fig. 2-3C). 
The 55S mitochondrial ribosome contains 2 rRNAs.  The 28S SSU contains a 12S 
rRNA and the 39S LSU contains a 16S rRNA.  In this organelle the rRNAs for both subunits 
are dramatically truncated relative to the prokaryotic rRNAs (Figs. 2-4) [6;7].  These rRNAs 
do not contain random deletions but rather distinct regions of secondary structures are absent.  
The mitochondrial equivalent of the peptidyltransferase center in the LSU and helix 44 in the 
SSU are conserved. 
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To complement the decrease in rRNA the mitochondrial ribosome has a greater 
number of ribosomal proteins.  This increase in ribosomal proteins was initially thought to 
replace regions of missing rRNA but cryoEM analysis has revealed that many of those 
regions are left devoid of both [5].  There are 77 ribosomal proteins that make up the full 
complement of ribosomal proteins.  The mitochondrial 28S SSU has 29 proteins of which 14 
have bacterial homologs: S2, S5, S6, S7, S9, S10, S11, S12, S14, S15, S16, S17, S18 and 
S21 [6].  The mitochondrial 39S LSU has 48 proteins of which 28 have bacterial homologs: 
L1, L2, L3, L4, L7/L12, L9, L10, L11, L13 - L24, L27, L28, L30 and L32 - L36.  The 
additional mitochondrial ribosomal proteins not listed have unknown functions but some may 
be involved in the interaction at the interface of the inner membrane of the mitochondrion 
and the ribosome during translation.  A striking difference between the intersubunit space in 
the mitochondrial ribosome and the prokaryotic ribosome is that the mitochondrial ribosome 
is dominated by protein:protein, as opposed to rRNA:rRNA interactions [5]. 
 
Leishmania tarentolae Mitochondrial Ribosomes 
 
Leishmania tarentolae is an organism in the family of trypanosomitids.  Members of this 
family include Trypanosoma brucei and Trypanosoma cruzi, which are known to cause 
African sleeping sickness and South American Chagas disease, respectively.  To combat 
these diseases and develop therapies, the mitochondrial (kinetoplast) ribosomes are under 
study.  The L. tarentolae mitochondrial ribosome is studied in lieu of T. brucei and T. cruzi 
because it is non-pathogenic and relatively easy to cultivate.  Interestingly, there have been 
varying reports of antibiotic sensitivities against the ribosomal particle.  Some reports 
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indicated susceptibility similar to that of the eukaryotic cytoplasmic ribosome [8;9] and 
others report similarities to the prokaryotic ribosome. 
A recent study revealed that the L. tarentolae mitochondrial ribosome was a 50S 
particle with a 30S SSU and a 40S LSU [10].  Based on EM studies of the 50S particle it has 
been suggested to have similar structural features to both the prokaryotic and mammalian 
mitochondrial ribosome such as the head and body of the SSU and the L1 stalk, central 
protuberance and the L7/L12 stalk on the LSU (Fig. 2-5A/B). 
The full protein complement of the 50S particle has not been determined but the 
rRNAs have been characterized.  The 30S SSU contains a 9S rRNA [11].  This rRNA lacks 
many of the domains relative to the prokarytic 16S SSU rRNA but retains the regions 
complementary to the A-site in the truncated helix 44 (Fig. 2-6).  The 40S LSU contains a 
12S rRNA which is also significantly shortened but nevertheless the peptidyl transferase 
center is conserved.  A complete secondary structure for this rRNA is not available. 
 In addition to the 30S SSU and the 40S LSU, other sedimentation particles have been 
observed and characterized.  The unique sedimentation particles identified are 70S, 65S and 
45S.  The 65S particle is believed to be a dimer of 40S LSU particles.  The 45S particle was 
characterized as having only SSU 9S rRNA and was therefore proposed to be a functional 
intermediate of the 30S SSU (Fig. 2-5C).  This particle was subsequently renamed the 45S 
SSU* [12].  The 70S particle was determined to be a dimer of the 45S SSU* particles.  The 
biological relevance of these particles are unknown and are quite unique to the trypanosomes.   
Developing a better understanding of the trypanosome kinetoplast ribosome will help 
to potentially develop antibiotics and therapies to combat this organism.  Therefore a 
bioinformatics analysis of the mass spectrometry data of the protein composition of the 45S  
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SSU* particle was thoroughly analyzed and implications for organellar evolution are 
discussed.  
 
MATERIALS AND METHODS 
 
Materials:  Chemicals were purchased from Sigma and Fisher Scientific.  Oligonucleotide 
primers were manufactured at the Nucleic Acids Core Facility (University of North 
Carolina).  All plasmids were purified using QIAGEN Qiaprep® Miniprep Handbook as 
described by the manufacturer.  Restriction enzymes were purchased from New England 
Biolabs.  Digested plasmids and PCR products were purified using the Qiagen Gel 
Extraction/PCR Purification Kit. 
 
Cloning of Mammalian Mitochondrial Ribosomal Proteins L13, L15, S2 and S11:  The 
cDNAs encoding human mitochondrial ribosomal proteins L13, L15, S2 and S11 (NCBI 
GeneID numbers 28998, 29088, 51116 and 64963, respectively) were ordered from 
American Type Culture Collection (ATCC).  The cDNA were amplified out of the stock 
pCMV-SPORT6 vector using the primers listed in Table 2-1.  The PCR products were 
digested with NdeI and XhoI along with purified pET(+)21b plasmid. The PCR product was 
ligated into the pET(+)21b plasmid at 16 °C for 16 hours under standard ligation conditions. 
The ligated plasmid was then transformed into Stratagene’s E. coli DH5α, sequenced and 
subcloned into Stratagene E. coli BL21 (DE3) RIL cells. 
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Growth and Expression of Mammalian Mitochondrial Ribosomal Proteins L13, L15, S2 and 
S11:  The E. coli BL21 RIL cells containing the genes for these proteins were used to 
inoculate 20 mL of LB containing 100 μg/mL ampicillin and 50 μg/mL kanamycin. This 
sample (20 mL) is used to inoculate 2 L LB media containing the appropriate antibiotic. 
These cells are grown with vigorous shaking (about 200 rpm) at 37 ° C to an A595 of 0.6 to 
0.8.   Expression was induced by the addition of 0.1 mM IPTG and is carried out at 27 °C 
overnight. Cells are harvested by centrifugation in 1 L bottles in a Sorvall RC3B centrifuge at 
5,000 rpm (7,300 x gmax) for 25 min at 4 ° C.  The cell pellets are resuspended in buffer 
containing 20 mM Tris-HCl (pH 7.6) and 10 mM MgCl2 and collected by centrifugation in 
50 mL falcon tubes in a RC5B Sorvall centrifuge using the SS34 rotor at 7,500 rpm (6,700 x 
gmax) for 25 min at 4 ° C. The supernatant was discarded and residual liquid carefully drained 
from the cell pellets. 
 
Ni-NTA Purification of Mammalian Mitochondrial Ribosomal Proteins L13, L15, S2 and 
S11:  The purification of these proteins followed the QIAexpressionist denaturing protocol 
from Qiagen.  If cell pellets were frozen they were first thawed for 15 min on ice and then 
resuspended in buffer B (100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, adjusted pH to 8.0) 
at 5 mL per gram wet weight.  Cells were stirred for 60 min at room temperature to lyse the 
cells.  The lysate was centrifuged at 10,000 x g for 30 min at room temperature to pellet the 
cellular debris.  The lysate was placed in a clean 50 mL orange cap tube and 1 mL of a 50% 
Ni-NTA slurry in Buffer B was added and the solution was rocked for 60 min at room 
temperature.  The lysate-resin was carefully added to a Qiagen 5 mL polypropolyene column 
and washed twice with 4 mL Buffer C (100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, 
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adjusted pH to 6.3).  Protein was eluted from the Ni-NTA resin in 0.5 mL fractions of Buffer 
E (100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, adjusted pH to 4.5), following a 30 min 
incubation for each fraction.  The proteins were then concentrated by placing all fractions 
into a dialysis tube and layering it with PEG 8000 to a final volume ~ 200 μL. 
 
Antibody Production against Mammalian Mitochondrial Ribosomal Proteins L13, L15, S2 
and S11:  Using the immunoadjuvant TiterMax Gold (R) a 250 μL emulsion of 125 μL 
TiterMax to 125 μL of concentrated protein (~250 μg).  Each emulsion was divided into two 
100 μL fractions per protein in sterile dispoable syringes and delivered to the UNC 
Veterinary Services where 4 New Zealand White Rabbits were used to produce the 
antibodies.  The rabbits were injected at 0, 4 and 8 weeks and blood was collected to test the 
serum at each injection time.  The final bleed was performed at 16 weeks and the rabbits 
were exsanguinated.  The antibodies were verified by Western blotting as described [13;14] 
 
Bioinformatics Analysis of the Protein of the L. tarentolae 45S SSU* particle:  The peptide 
fragments obtained from the trypsin digested L. tarentolae mitochondrial 45S SSU* particles 
LC/MS/MS proteomic analysis were used in a BLASTP query against bacteria, yeast and 
eukaryota databases.  E-values smaller than 1e-03 were considered significant. 
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RESULTS 
 
Mammalian Mitochondrial Ribosomes 
 
If one could capture the mitochondrial ribosome with factors intact, we could learn a 
tremendous amount about protein synthesis in this organelle.  To this end, and based on the 
assumption that mitochondrial ribosomal proteins with prokaryotic homologs would be 
located on the mitochondrial ribosome in the same relative orientation to that of their 
prokaryotic counterparts on the prokaryotic ribosome, the crystal structures of the 
prokaryotic subunits were examined for ribosomal proteins that were accessible and would 
not interfere in factor binding.  After a thorough analysis of both the Haloarcula marismortui 
50S LSU and the Thermus thermophilus 30S SSU, four ribosomal proteins with 
mitochondrial homologs fit the criteria:  L13, L15, S2 and S11 (Fig. 2-7).   
As described in Materials and Methods, the mammalian mitochondrial ribosomal 
proteins were all cloned and expressed successfully (Fig. 2-8A).  Antibody production 
proceeded without incident and the antibodies were very specific for a single antigen in the 
mitochondrial ribosomes (Fig. 2-8B).  Interestingly in the case of MRPS11, the antibody 
revealed isoforms of this protein not previously observed.  This isoform was confirmed by 
using the MRPS11 gene as a query in a BLASTP search against the Homo sapiens EST 
database at NCBI.  Further analysis and experimentation with these antibodies was not 
performed due to a loss of funding and a refocusing of effort on other projects.   
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Leishmania tarentole Ribosomal Analysis 
 
The LC/MS/MS peptide fragment data of the trypsin digested 45S SSU* Leishmania 
tarentole ribosomal particle was first analyzed by MASCOT against the Leishmania major 
Gene Database, http://www.genedb.org/genedb/leish/.  A representative table of proteomic 
hits is shown in Table 2-2.  A more thorough analysis of the initial hits was performed to 
determine which hits were significant Leishmania SSU ribosomal proteins. 
Seven homologs of small subunit ribosomal proteins identified earlier in the analysis 
of the mixed 45S/50S fraction [10] (S5, S9, S11, S15, S16, S17, S18) and three additional 
components (S6, S8, MRPS29) have been found in the 45S SSU* complexes. The degree of 
sequence conservation varies greatly among these polypeptides. Thus, the identification of 
the S5, S8, S17 and MRPS29 homologs was based on BLAST searching that yielded highly 
significant E-values smaller than the conventional 1e-03 cut-off value.  
Although the BLAST E-scores for S11 similarity hits were not significant (E ≥ 0.51), 
this protein was found to contain the RNase H-like SCOP domain (E = 3e-07) present in the 
ribosomal protein family including S11 and L18, as well as the NCBI conserved domain 
RpsK (representing ribosomal protein S11) (E = 0.0001). Similarly, the best BLAST E-score 
for the S9 homolog was only 0.12. Nonetheless, the identification of this protein is reliable: it 
was based on finding ribosomal protein S5 domain 2-like SCOP domain (E = 4e-16) present 
in the S5 and S9 ribosomal protein families; and finding the Ribosomal_S9 Pfam domain (E 
=0.0008). 
The S15 homolog was identified based on the similarity with putative mitochondrial 
S15 proteins from Theileria annulata (E=0.009) and Schizosaccharomyces pombe (E=0.037)   
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and the presence of the S15/NS1 RNA binding SCOP domain (E=0.014).  The identification 
of the putative S6, S16 and S18 homologs was not strongly supported. The putative S6 
homolog was identified only by a weak similarity to several mitochondrial S6 proteins. The 
S16 protein was moderately similar to fungal MRPS24 (S16 family) (E ≥ 0.038). The S18 
protein was found to contain the SCOP ribosomal protein S18 domain (1.80e-02) but 
demonstrated only a weak similarity to the corresponding eubacterial proteins.  
To summarize from above, the proteomics analysis indicated the presence of 10 
candidates for SSU proteins in the trypanosome SSU* complexes. This number is somewhat 
smaller than the 14 prokaryotic homologs found in the bovine mitochondrial 28S SSU. With 
the exception of S8, all of the homologs observed in Leishmania are also observed in 
mammalian mitochondrial ribosomes. In general the similarity between the Leishmania SSU 
homologs and the bacterial proteins is somewhat higher than the similarity observed between 
the Leishmania SSU homologs and homologs observed in other mitochondrial translational 
systems. This observation suggests that different constraints have been placed on the 
mitochondria of different organisms during evolution leading to considerable divergence in 
the ribosomal proteins.   
To further this analysis, the cytoplasmic ribosomal proteins of Leishmania major, 
Saccharomyces cerevisiae, and Homo sapians and the mitochondrial ribosomal proteins 
identified in the 45 SSU* analysis were used as a query in a BLASTP analysis against the all 
eubacteria in the NCBI database.  The expected result is homology between the bacterial 
ribosomal proteins with the mitochondrial proteins from these organisms.  This expectation is 
based on the assumption that the mitochondrial ribosomal proteins are under less selective 
pressure to evolve from their bacterial protein progenitors.  Quite unexpected was the result   
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that the cytoplasmic ribosomal proteins of Leishmania major are more like bacterial 
ribosomal proteins than the Leishmania major mitochondrial ribosomal proteins.  A summary 
of the findings are listed in Table 2-3. 
 
DISCUSSION 
 
Mammalian Mitochondrial Ribosomes 
 
Although further analysis of the human mitochondrial ribosomal protein antibodies was not 
performed these factors will potentially be used in future experiments.  They were initially 
conceived to develop a ribosome capture assay.  This assay would have used these antibodies 
by immobilizing them on beads and mitochondrial lysates would have been washed over 
them, potentially capturing the ribosomal complexes.  In theory, these complexes could 
contain novel proteins involved in the mitochondrial translation machinery.  These 
complexes would have been enriched and analyzed using a proteomics approach, similar to 
that of the Leishmania 45S SSU* analysis. 
 
Leishmania tarentole Ribosomal Analysis 
 
The BLASTP analysis performed on the 45 SSU* particle reflects the relationship between 
the mitochondrial, cytoplasmic and bacterial ribosomal proteins. The classical view of the 
endosymbiotic origin of mitochondria leads to the idea that components of the translational 
system in these organelles should be more closely related to those of bacteria than are 
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components of the cytoplasmic translational system. To examine this issue in Leishmania, we 
have BLASTed the Leishmania mitochondrial and cytoplasmic ribosomal proteins against all 
eubacteria in the NCBI database. This analysis was carried out with 5 of the ribosomal 
proteins, which are represented in all three categories of ribosomes (prokaryotic, cytoplasmic 
and mitochondrial). As indicated in Table 2-3, for 4 out of the 5 proteins, the Leishmania 
cytoplasmic ribosomal protein was more closely related to its bacterial homolog than was the 
corresponding mitochondrial homolog. This observation is somewhat surprising and 
indicates that the evolutionary divergence of mitochondrial ribosomal proteins in the 
trypanosomes has been surprisingly rapid. To place this analysis in context, a similar analysis 
was carried out with yeast and mammalian cytoplasmic and mitochondrial ribosomal 
proteins.  Of the 5 proteins for which an analysis could be carried out, 3 yeast mitochondrial 
ribosomal proteins are more closely related to bacteria than the corresponding cytoplasmic 
homolog. In mammals, only 4 proteins could be examined in this way due to the loss of S8. 
Of these, two mitochondrial homologs are closer to bacteria, one protein has the same 
BLAST score and one cytoplasmic ribosomal protein is closer to bacteria than the 
mitochondrial homolog. This analysis suggests that the Leishmania mitochondrial ribosomal 
proteins have diverged more from bacteria than have most other mitochondrial ribosomal 
proteins. However, surprisingly, mitochondria from a variety of very diverse organism have 
some mitochondrial ribosomal proteins that have become more distant from bacteria than the 
corresponding cytoplasmic ribosomal proteins. This observation reflects a more rapid 
evolution of mitochondrial components to that of the cytoplasmic components.  
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CHAPTER III 
 
ANALYSIS OF THE ROLES OF THE NKXD MOTIF AND THE INSERTION 
DOMAIN IN MAMMALIAN MITOCHONDRIAL INITIATION FACTOR 2 
 51 
INTRODUCTION 
 
Structure of IF2:  Mammalian mitochondria have a translational system responsible for the 
synthesis of 13 proteins required for oxidative phosphorylation in the inner membrane.  In 
this system, mitochondrial IF2 (IF2mt) stimulates the binding of fMet-tRNA
fMet 
to the 28S 
small subunit of the mitochondrial ribosome in the presence of GTP and mRNA [1;2].  As 
described in Chapter I, IF2 is a guanine nucleotide binding protein (G-protein or GTPase) 
and recruits fMet-tRNA
fMet 
into the P-site of small subunit of the ribosome forming the 
initiation complex to begin protein synthesis [3].   
The secondary structure of IF2mt is based on the six domain model of E. coli IF2 [4] 
(Fig. 3-1A).    In E. coli IF2 the role of domain I is not known.  The two isoforms of IF2, 
IF2α, consisting of domains I - VI, and IF2β, which lacks domain I, are both functionally 
active in vivo and in vitro [5;6].  Domain II was shown to be directly involved in the binding 
of this factor to the 30S small subunit (SSU) of the E. coli ribosome [7].  Interestingly, an IF2 
variant lacking both domains I and II can bind 30S subunits only in the presence of initiation 
factor 1 (IF1) [4], suggesting that the N-terminus of IF2 provides an important part of the 
SSU binding activity of this factor.  It has also been proposed that fMet-tRNA
fMet 
stabilizes 
the interaction of IF2 with the ribosome for factors that lack the N-terminal domains [8].  No 
specific role of domain III has been demonstrated beyond its role in connecting domains II 
and IV [9].  Domain IV is the G-domain, where the GTPase activity of this factor is located, 
and in all IF2s this domain is very highly conserved.  This domain has also been implicated 
as a potential metabolic sensor [10].  Domain V has no known function but has been 
proposed that, together with IF1, it could mimic the structure of elongation factor G at the A- 
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site of the ribosome [11].  Domain VI is divided into two subdomains C1 and C2, the latter of 
which is directly involved in interacting with the fMet-tRNA
fMet 
[12-16].  IF2mt is 
characterized as having four domains equivalent to domains III – VI of the E. coli factor.  It 
has an insertion between domains V and VI that has a unique function in this factor [17].   
The 3-dimensional structure of IF2 is not known but the structure of an archaeal 
homolog, Methanobacterium thermoautotrophicum aIF5B, which consists of domains IV 
through VI, reveals a chalice like structure with domains IV - VI C1 forming the cup and VI 
C2 forming the base [18] (Fig. 3-1B).  The N-terminal region of IF2 was studied using NMR 
and CD analysis and was found to have a well ordered structure even though this factor can 
function with these domains truncated [19].   
 
The G-Domain of IF2:  Of particular interest is domain IV, the G-domain.  In IF2mt the G-
domain is 66 % identical to the G-domain of E. coli IF2 [20] and 43 % identical to the G-
domain M. thermoautotrophicum aIF5B.  It shares a common structural core with the G-
domains of other G proteins, including the G-domain of EF-Tu and EF-G [11;21].  A number 
of G-proteins are involved in protein synthesis and are required in all 3 major steps of 
translation:  initiation, elongation and termination.   
G-proteins are characterized by 5 conserved motifs [22] (Fig. 3-2A).  G-1 
(GXXXXGKS/T) coordinates the α- and β-phosphates of the guanine nucleotide.  G-2 (XTX) 
is thought to coordinate a Mg
2+
 ion.  G-3 (DXXG) aids in the coordination of the Mg
2+
 and 
the γ-phosphate of GTP.  G-4 (NKXD) and G-5 (SAL/K) in IF2s are important in selecting 
and positioning the guanine ring.  Mutations in the motifs of the G-domain often lead to cold 
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sensitive phenotypes in E. coli IF2 [23;24] or can be lethal [21;25] illustrating of the 
importance of the G-domain for the function of IF2.   
The NKXD motif interacts with the guanine ring through a hydrogen bond between 
the amine of asparagine (N) and the O6 position of the guanine ring and through a hydrogen 
bond between the carboxyl group of the aspartatic acid (D) and the 2’ amine of the guanine 
ring (Fig. 3-2B).  In aIF5B, the X residue, isoleucine (I), is pointing away from the guanine 
ring and is largely buried in the G-domain.  The X residue in the NKXD motif is not truly 
random but partially conserved in homologous proteins (Fig. 3-3).  In IF2mt this residue is 
present as Cys290.  In IF2 the X residue is generally methionine (M), valine (V), cysteine (C) 
or isoleucine (I).  In elongation factor EF-Tu, this residue is generally valine (V), methionine 
(M), isoleucine (I) or leucine (L).  While for release factor 3 it is leucine (L), methionine 
(M), tyrosine (Y) or tryptophan (W).  In the work described below the Cys290 in bovine 
IF2mt was mutated to serine (S), alanine (A) and isoleucine (I) and the effects of these 
changes on the activity and stability of this protein were assessed. 
 
The Insertion Region of IF2mt:  An interesting characteristic of IF2mt is the presence of an 
insertion sequence between domains V and VI (Fig. 3-1), which is strongly conserved 
amongst IF2mt across various species [17].  In bovine IF2mt this sequence consists of 37 
amino acids which are very hydrophilic with a high percentage of acidic and basic residues 
(Fig. 3-4B).  A partial structural model of IF2mt based on the pdb coordinates of M. 
thermoautotrophicum aIF5B was generated by Swiss-Model [26]. The model consists of the 
conserved regions of domain IV and domains V-VI C2 and indicates that there is a 
significant degree of structural conservation between IF2mt and aIF5B. The most obvious  
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difference between the two structures lies in the insertion region of IF2mt.  The model 
predicts that this region loops out and protrudes from the surface of the molecule (Fig. 3-4B). 
Several models for the binding of IF2 to the small ribosomal subunit [8;27;28] would place 
the insertion near the A-site where IF1 binds [27;29] (Fig. 3-5).   
No homolog of IF1 has been detected in mitochondria from any organism ranging 
from yeast to man, despite database searching and biochemical probing [30].  IF1 is an 
essential factor in both prokaryotes and in the eukaryotic cell cytoplasm (eIF1A) and it would 
be surprising if no equivalent factor were present in mitochondria.  The insertion region in 
IF2mt is the most reasonable region to serve the role of IF1 for the mitochondrion.   Initial 
experiments on the role of the insertion in IF2mt in translational initiation were investigated 
by site-directed mutagenesis.  Several highly conserved lysines and arginines residues in the 
insertion were changed to Ala [31] and the resulting mutants showed decreased ability to 
bind 28S subunits but retained their ability to bind fMet-tRNA
fMet
.  These results indicate that 
the residues in the insertion may make important ribosomal contacts between this factor and 
the small ribosomal subunit [17]. 
In the current work, the role of the insertion domain in IF2mt was examined by 
removing the entire insertion in IF2mt and replacing it with the equivalent, smaller, region 
from E. coli IF2 (IF2mtΔ37).  In a complementary experiment, the insertion observed in 
IF2mt was placed into E. coli IF2 (EcoIF2::37).  These hybrid IF2s were assayed for their 
response to IF1 in initiation complex formation on both E. coli and mitochondrial ribosomes.  
Furthermore, in vivo assays by our collaborators in India (Dr. Umesh Varshney) with the 
wild-type IF2mt and these hybrid factors were evaluated for their ability to rescue an E. coli 
IF2 knock-out and a double IF1/IF2 knock-out using a P1 transduction strategy.  In E. coli it  
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should be noted that both IF1 and IF2 genes are essential and a knockout of either one is 
lethal [6;32]. 
 
MATERIALS AND METHODS 
 
Materials:  Chemicals were purchased from Sigma and Fisher Scientific.  Oligonucleotide 
primers were manufactured at the Nucleic Acids Core Facility (University of North 
Carolina).  [
35
S]Met was purchased from Perkin Elmer.  [
35
S]fMet-tRNA
fMet 
was prepared as 
described [33;34].  E. coli and mitochondrial ribosomes and ribosomal subunits were 
prepared as described [34-36].  E. coli IF3 and mammalian mitochondrial IF3 (IF3mt) were 
prepared as described [30].  The previously cloned plasmids carrying the mature form of the 
IF2mt coding sequence [33] in the pET21b plasmid, E. coli factors in pET21b plasmids and 
all other plasmids were purified using QIAGEN Qiaprep® Miniprep Handbook as described 
by the manufacturer.  Restriction enzymes were purchased from New England Biolabs.  
Digested plasmids and PCR products were purified using the Qiagen Gel Extraction/PCR 
Purification Kit. 
 
Site-Directed Mutagenesis of the X residue of NKXD motif in IF2mt:  Purified plasmid DNA 
(pET21b IF2mt) was used for site directed mutagenesis using Stratagene’s QuikChange® 
Site-Directed Mutagenesis Kit as described by the manufacturer.  The primers used are listed 
in Table 3-1.  The PCR reactions (100 µL) contained 10 µL 10x Pfu Buffer (Stratagene), 
~100 ng pET21b IF2mt DNA, 0.5 mM dNTPs, ~250 ng forward primer, ~250 ng reverse 
primer and 2.5 units of PfuTurbo DNA polymerase.  These reactions were run in an Ericomp 
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Thermocycler under the following conditions:  Cycle 1 (95 °C, 1 min) x 1, Cycle 2 (95 °C, 1 
min; 55 °C, 1 min; 65 °C, 8 min) x 18, Cycle 3 (4 °C, 99 h).  The reaction mixtures were 
transformed into E. coli ER2267 competent cells using Stratagene’s protocols.  The presence 
of the mutation was confirmed by DNA sequencing at the UNC-CH Genome Analysis 
Factility.  Variant IF2mt plasmids were then transformed into E. coli BL21(DE3) cells, 
containing a pArgU218 plasmid (provided by Dr. Yamada, Mitsubishi Chemical Corp., 
Yokohama, Japan), for expression. 
 
Subcloning of the IF2mt with Insertion Replaced by the E. coli Domain V/VI Junction:  Our 
collaborators in India, Dr. Umesh Varshney and Rahul Gaur (Bangalore, Indian Institute of 
Technology), created a variant of IF2mt with the insertion deleted and replaced with the 
corresponding sequence in E. coli IF2 (EcoIF2), creating the variant IF2mtΔ37, in a pTrc 
vector (Fig. 3-6).  The IF2mtΔ37 gene was amplified from the pTrc vector by PCR under the 
same conditions as above, with primers listed in Table 3-1.  The IF2mtΔ37 PCR product was 
digested with NdeI and NcoI and ligated into the expression vector pET24b, that provides 
kanomycin resistance and provides a C-terminal 6x His tag, under standard ligation 
conditions (16 h at 16 °C).  The ligated pET24b IF2mtΔ37 plasmid was transformed into 
Stratagene E. coli DH5α competent cells for plasmid production and Stratagene E. coli BL21 
RIL competent cells for expression. 
 
Creation of EcoIF2 with IF2mt Insertion (EcoIF2::37):  Using the pET21b EcoIF2 stock 
previously cloned in our lab, two site directed mutagenesis reactions were performed to insert 
PmlI, and BamHI sites into the E. coli IF2 sequence creating silent mutations.  These two  
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restriction sites were chosen because they were not present in the gene sequence and they 
required minimal mutations.  The silent mutation primers used are listed in Table 3-1 and the 
PCR conditions are the same as the NKXD site-directed mutations.  For PmlI a G to A silent 
mutation in the EcoIF2 gene was created as underlined (1950CACGTG1955).  For BamHI two 
silent mutations were created in the EcoIF2 gene, a T to A and T to C as underlined 
(2095GGATCC2100).  The sequence to be inserted into the pET21b EcoIF2 was cloned out of 
IF2mt with primers listed in Table 3-1, PCR was performed under the same conditions as 
above, and the PCR product and mutated pET21 EcoIF2 plasmid were digested with PmlI 
and BamHI and subsequently ligated under standard conditions for 16 h at room 
temperature.  The ligated pET21b EcoIF2::37 plasmid was transformed into Stratagene E. 
coli DH5α competent cells for plasmid production and then into E. coli BL21(DE3) cells, 
containing a pArgU218 plasmid. 
 
Growth of Cells, Induction and Preparation of Cell Extracts: A sample of a frozen stock of E. 
coli BL21 cells carrying the coding region for the variant IF2 in the corresponding pET 
vector was used to inoculate 20 mL of LB containing the appropriate antibiotics as indicated.  
The BL21(DE3) pArgU218 pET21 IF2mt, and all IF2mt NKXD variants, required 100 
μg/mL ampicillin and 50 μg/mL kanamycin.  The BL21(DE3) pET21 EcoIF2 required 100 
μg/mL ampicillin.  The BL21(DE3) RIL pET24d IF2mtΔ37 required 34 μg/mL 
chloramphenicol and 50 μg/mL kanamycin.  The BL21(DE3) pArgU218 pET21 EcoIF2::37 
required 50 μg/mL kanamycin  and 100 μg/mL ampicillin.  This bacterial sample (20 mL) 
was used to inoculate 2 L LB media containing the appropriate antibiotics. These cells were 
grown with vigorous shaking (about 200 rpm) at 37 ° C to an A595 of 0.6 to 0.8.   Expression 
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was induced by the addition of 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and 
was carried out at 27 °C overnight. Cells were harvested by centrifugation in 1 L bottles in a 
Sorvall RC3B centrifuge at 5,000 rpm (7,300 x gmax) for 25 min at 4 °C.  The cell pellets 
were resuspended in buffer I (20 mM Tris-HCl (pH 7.6) and 10 mM MgCl2) and collected by 
centrifugation in 50 mL falcon tubes in a RC5B Sorvall centrifuge using the SS34 rotor at 
7,500 rpm (6,700 x gmax) for 25 min at 4 °C. The supernatant was discarded and residual 
liquid carefully drained from the cell pellets. The pellets were either immediately lysed by 
sonication or fast frozen in a dry ice-isopropanol bath and stored at -80 °C.   
The cell pellet (~ 8 g) was resuspended in five volumes (5 mL/g cells) of ice cold 
Buffer II (20 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 1 M KCl, 10 mM imidazole, 5 mM β-
mercaptoethanol and 0.1 mM phenylmethylsulfonyl fluoride) by gentle mixing.  Lysozyme 
(~ 1 mg) was added to the mixture followed by DNase I (to 5 µg/mL).  The mixture was 
placed in an ice bath and sonicated in 1 s bursts with 9 s off for 7 cycles (70 sec total) using a 
Branson SONIFER Cell Disruptor 185 with a power setting of 9 (130 W).  The solution was 
then adjusted to a final concentration 1 M NH4Cl by the addition of solid NH4Cl while 
stirring. The sample was stirred for an additional 15 min at 0 °C after the salt concentration 
had been adjusted.  The solution was subjected to centrifugation in a Beckman L8-70 
ultracentrifuge using a Sorvall TFT 50.38 rotor for 1 h at 28,000 rpm (71,000 x gave) at 4 °C.  
The supernatant was removed and further processed with Ni-NTA resin as described below. 
  
Purification of IF2 variants by Ni-NTA resin: The sample from sonication (~50 mL) was 
mixed for 40 min at 4 °C with a 50 % slurry of Ni-NTA agarose resin (0.2 mL resin per g 
original cell weight) equilibrated in Buffer II.  Incubation was carried out on a shaking 
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platform so that the sample was mixed gently during incubation with the resin. This mixture 
was transferred to a 5 mL polypropylene column (Qiagen).  The resin was washed with an 
excess of Buffer II (at least 50 mL) and the variant IF2 was eluted from the resin using 
approximately 10-15 mL Buffer III (20 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 50 mM KCl, 
150 mM imidazole, 5 mM β-mercaptoethanol and 0.1 mM phenylmethylsulfonyl fluoride) 
using 1-2 mL/g original cell weight. This step was done by three sequential elutions of about 
5 mL each.  Each aliquot of Buffer III was incubated with the resin for 15 min at 4 °C before 
it was collected.  The aliquots were combined and dialyzed against a 100-fold excess of 
Buffer IV (20 mM Hepes-KOH (pH 7.6), 10 mM MgCl2, 50 mM KCl, 10 % glycerol and 6 
mM β-mercaptoethanol) at 4 °C for 1.5 h with one change of buffer after 45 min. 
 
Purification of NKXD IF2mt variants by HPLC:  The dialyzed sample from the Ni-NTA 
resin was passed through a 0.45 μm filter and then injected into a 10 mL loop on the Rainin 
Rabbit HPLC injection port.  The sample was applied to a TSKgel DEAE 5PW HPLC 
column (7.5 cm x 7.5 mm, TosoHaas Inc., Japan) equilibrated in Buffer IV at a flow rate of 
0.5 mL/min.  This step was carried out at 4 °C controlled by the Macintosh computer sitting 
outside a cold box. The column was washed for at least 20 min with Buffer IV and then 
developed with a linear gradient (50 mL) from 0.05 to 0.25 M KCl in Buffer IV at a flow rate 
of 0.5 mL/min.  The absorbance at 280 nm was monitored with an ISCO UA6 UV Visible 
detector and a chart recorder set to the 0.5 scale with a chart speed of 30 cm/h. The flow cell 
has a path length of 0.5 cm. Fractions (0.5 mL) were collected in Eppendorf tubes using an 
ISCO RETRIEVER 500 fraction collector. The Eppendorf tubes had the lids removed and 
were balanced in 13 x 100 mm glass test tubes.  The fractions were fast frozen in a dry ice 
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isopropanol bath and stored at -70 °C.  Fractions containing the IF2mt variant were identified 
by 10 % SDS polyacrylamide gel electrophoresis and staining with Coomassie Blue using 20 
μL aliquots of the appropriate fractions. The presence of IF2mt was verified by Western 
blotting as described [17;33]. The appropriate fractions are pooled accordingly. The IF2mt 
variants eluted at a KCl concentration of approximately 0.12 M.   
 
Purification of IF2 Variants on a Gravity DEAE-Sepharose Column: The dialyzed sample 
from the Ni-NTA column was applied to a ~10 ml (5.7 x 1.5 cm) DEAE-Sepharose anion 
exchange column. The column was washed with 100 mL Buffer IV containing 100 mM KCl 
until the absorbance at 280 nm was near the baseline. A linear gradient (40 mL) from 100 
mM - 300 mM KCl in Buffer IV was applied to the column at a flow rate of 0.75 mL/min.  
The absorbance at 280 nm was monitored with an ISCO UA6 UV Visible detector at a 
setting of 0.5 and a chart speed of 30 cm/h.  Fractions (0.75 mL) were collected in Eppendorf 
tubes at a flow rate of 0.75 mL/min.  Fractions containing mature IF2mt were identified by 
10 % SDS-polyacrylamide gel electrophoresis (Fig. 3B) and pooled. The sample was fast 
frozen in a dry-ice isopropanol bath and stored at -70 °C.  IF2mt eluted at a KCl 
concentration of approximately 0.22 M.  
 
Assays of IF2 variants on 70S E. coli Ribosomes: Reaction mixtures (0.1 mL) contained 50 
mM Tris-HCl (pH 7.8), 5 mM MgCl2, 80 mM KCl, 0.25 mM GTP, 1.25 mM 
phospho(enol)pyruvate, 0.37 units of pyruvate kinase, 1 mM dithiothreitol (DTT), 12.5 µg 
poly(A,U,G), 0.06 µM (6 pmol) [
35
S]fMet-tRNA
fMet
 [approximately 70,000 counts per min 
(cpm)/pmol], 0.24 µM (24 pmol) E. coli IF3,  0.24 µM (58 µg) E. coli 70S ribosomes, and 
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the various amounts of the IF2 variants.  These assays were also performed in the presence of 
0.50 μM (50 pmol) IF1 where indicated.  When dosing with IF1 instead of with IF2 the 
concentration of IF2 was held constant at the indicated concentration.  Samples were 
incubated at 37 °C for 15 min.  After incubation, each sample was rapidly diluted with 3-4 
mL of cold Mg5 Wash Buffer (50 mM Tris-HCl (pH 7.8), 5 mM MgCl2, 80 mM KCl) and 
filtered through a nitrocellulose membrane (Millipore HAWG) that had been wetted with 
cold Mg5 Wash Buffer.  Filtration was facilitated by use of a gentle vacuum created by a 
pump. The filters were washed with 3 aliquots (3-4 mL each) of cold Mg5 Wash Buffer with 
the vacuum on.  Filters were dried at 100 °C for 5-7 min and counted in 5 mL toluene 
containing 5 g/L 2,4 diphenyloxazole (PPO) scintillation cocktail. 
 
Assays of IF2 variants on Bos taurus (Bovine) 55S Mitochondrial Ribosomes: Reaction 
mixtures (0.1 mL)  contained 50 mM Tris-HCl (pH 7.8), 7.5 mM MgCl2, 35 mM KCl, 0.25 
mM GTP, 1.25 mM phospho(enol)pyruvate, 0.37 units of pyruvate kinase, 1 mM DTT, 12.5 
µg poly(A,U,G), 0.06 µM (6 pmol) [
35
S]fMet-tRNA
fMet
 (approximately 70,000 cpm/pmol), 
0.2 µM IF3mt, 0.06 µM (6 pmol) 55S mitochondrial ribosomes (1 A260 is 32 pmol of 55S 
ribosomes) and the desired amount of the IF2 variants.  These assays were also performed in 
the presence of 0.50 μM (50 pmol) E. coli IF1 where indicated.  When dosing with IF1 
instead of IF2, the concentration of IF2 was held constant at the indicated concentration. 
Samples were incubated at 37 °C for 15 min and then treated as described above except that 
Mg7.5 Wash Buffer (50 mM Tris-HCl (pH 7.8), 7.5 mM MgCl2, 35 mM KCl) was used.  
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RESULTS 
 
NKXD Variants of IF2mt 
 
Preparation and Expression of the NKXD IF2mt Variants:  Analysis of sequence alignments 
of IF2s using the National Center for Biotechnology Information’s (NCBI) BLAST and 
Conserved Domain Database (CDD) programs indicates that the X residue of the NKXD 
motif is not random but rather is generally present as isoleucine, valine, methionine or 
cysteine (Fig. 3-3).  This observation suggests that a limited repertoire of residues can be 
accommodated as the X residue in IF2.  There is no clear pattern between organisms (gram 
negative, gram positive or organelle) and the X residue in IF2s.  To investigate the range of 
residues that can be accommodated at the X position, this residue in bovine IF2mt (cysteine 
at position 290) was mutated to alanine , isoleucine and serine.   
The wild-type and mutated proteins were expressed in E. coli as His-tagged proteins 
and their expression was examined by Western blotting following purification on Ni-NTA 
resins.  As indicated in Fig. 3-7 the wild-type protein was present as a major band at 73 kDa.  
In addition to the full-length protein product a number of other bands were observed in these 
preparations.  Western blot analysis indicated that the majority of these were degradation 
products (Fig. 3-7) which could be removed by HPLC [17].  Expression of the C290S variant 
was similar to that of the wild-type IF2mt.  This observation suggests that replacement of the 
cysteine residue by serine allows the protein to fold correctly.  In contrast to wild-type IF2mt 
and the C290S variant, replacement of C290 by alanine resulted in a severe reduction in the 
amount of full-length protein obtained.  Essentially no full-length polypeptide product was  
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observed in these preparations.  Western blotting indicated the presence of significant 
amounts of degradation products.  These observations suggest that replacement of C290 by 
alanine results in a protein in which the G-domain fails to fold properly resulting in an 
unstable factor.  When C290 was replaced by isoleucine, a common residue in the X position 
in IF2s, a similar problem with the stability of the protein was observed.  Again, this variant 
of IF2mt failed to fold and no full-length protein was observed, only degradation products 
were visualized.  The potential that these proteins went into inclusion bodies was evaluated 
by purifying them under denaturing conditions.  However, no additional bands were observed 
(data not shown). 
 
Activity in Initiation Complex Formation of the NKXD Variants:  The low level of 
expression of the C290A and C290I variants precluded testing their activities in initiation 
complex formation.  However, the activity of the C290S variant was tested on both E. coli 
70S ribosomes and mitochondrial 55S ribosomes.  The C290S was as active as wild-type 
IF2mt in initiation complex formation on the 70S ribosome (Fig. 3-8A).  This variant was 
also as active as wild-type IF2mt in promoting the binding of fMet-tRNA
fMet 
to 
mitochondrial 55S ribosomes (Fig. 3-8B). 
 
Role of the Insertion Between Domains V and VI on the Activity of IF2mt and its 
Response to IF1 
 
Preparation and Expression of IF2mtΔ37 and EcoIF2::37:  IF2mt has a conserved insertion 
between domains V and VI that has been investigated to determine its role in initiation.   
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Based on structural analysis of E. coli IF2 (EcoIF2) and its placement on the 
prokaryotic SSU, the mitochondrial insertion has been proposed to interact in the same 
region on the SSU as IF1.  To further examine the role of the insertion domain the entire 
insertion in IF2mt was removed and replaced with the equivalent region from E. coli IF2 
(Fig. 3-6).  IF2mtΔ37 was prepared by our collaborators in India, Dr. Umesh Varshney and 
Rahul Gaur.  This variant of IF2mt has the insertion deleted and replaced with the 
corresponding sequence in E. coli IF2, forming IF2mtΔ37.  The region of E. coli IF2 
spanning the insertion was used to replace the insertion and a number of flanking residues 
using conserved sequences in domains V and VI to anchor the ends of the deletion. For this 
purpose, amino acid residues 654-698 of EcoIF2 were used to replace residues 444-525 of 
IF2mt (Fig. 3-6).  Silent mutations were engineered to introduce the necessary restriction 
sites.  The IF2mt insertion region is flanked by residues homologous to E. coli IF2, 440 
AREV 403 and 526 GSVE 529 on the N and C terminal borders of the insertion, 
respectively.  This strategy is analogous to that used in deleting the coiled-coil region of E. 
coli EF-Ts and its replacement with a bridging linker derived from EF-Tsmt [37;38].  In the 
complementary experiment to that of the IF2mtΔ37 hybrid, the insertion observed in IF2mt 
was inserted into E. coli IF2 using the cloned His-tagged form of this factor to create the 
EcoIF2::37 hybrid.  The same flanking regions as above were used to amplify the IF2mt 
insertion and ligate it into EcoIF2 using the PmlI and BamHI restriction sites, previously 
described (see scheme Fig. 3-6D).   
Cells expressing both IF2mtΔ37 and EcoIF2::37 were grown, expressed and purified 
according to the IF2mt variant purification protocol.  Both proteins expressed well and their 
activities were analyzed in 70S (Figs. 3-9, 3-10) and 55S (Fig. 3-11) initiation complex 
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formation assays in the presence and absence of IF1.  Both IF2mtΔ37 and EcoIF2::37 were 
assayed separately using the same controls, namely wild-type EcoIF2 and IF2mt.  EcoIF2 
and IF2mt served as benchmarks to compare each assay because their activities have been 
previously characterized. 
The activity of IF2mtΔ37, IF2mt lacking the insertion region, in the presence and 
absence of IF1 on 70S prokaryotic ribosomes is shown in Figure 3-9.  In the absence of IF1 
(Fig. 3-9A) IF2mtΔ37 shows a modest activity.  The activities of wild-type EcoIF2 and 
IF2mt were modest and quite active, respectively.  The modest activity of EcoIF2 is not 
unexpected; this factor is known to require IF1 to be fully functional.  The IF2mtΔ37 has 
approximately the same activity as EcoIF2.  In the presence of IF1 (Fig. 3-9B), the activity of 
IF2mtΔ37 appears stimulated about 5-fold.  Additionally, the activity of EcoIF2 is stimulated 
nearly 10-fold, as expected, and is comparable to that of IF2mt.  Dosing IF1 (Fig. 3-9C) 
against constant amounts of IF2s reveals that IF2mtΔ37 shows a clear response to the 
addition of this factor and now mimics the response of EcoIF2.  IF2mt shows no IF1 dose 
response.  
The activity of EcoIF2::37, E. coli IF2 with the IF2mt insertion, in the presence and 
absence of IF1 on 70S prokaryotic ribosomes is shown in Figure 3-10.  In the absence of IF1 
(Fig. 3-10A) EcoIF2::37 shows an anemic activity.  The activities of wild-type EcoIF2 and 
IF2mt were the same as the previous experiment.  In the presence of IF1 (Fig. 3-10B), the 
activity of EcoIF2::37 appears slightly improved, although still very anemic.  EcoIF2 and 
IF2mt respond as previously noted.  Dosing of IF1 (Fig. 3-10C) against constant amounts of 
IF2 revealed that EcoIF2::37 shows negligible response to the addition of this factor and now 
resembles the response of IF2mt. 
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The 55S mitochondrial initiation complex activity assays were performed on IF2mt, 
EcoIF2, IF2mtΔ37 and EcoIF2::37 in the presence and absence of IF1 (Fig. 3-11A/B) and 
also with increasing concentrations of IF1 (Fig. 3-11C) as previously described.  These 
assays revealed little because EcoIF2, IF2mtΔ37 and EcoIF2::37 are not active on 55S 
mitochondrial ribosomes.  Clearly the insertion in IF2mt is very important in initiation 
complex formation on 55S mitochondrial ribosomes.  The IF2mt variant lacking the 
insertion, IF2mtΔ37, has approximately 5 % of the activity of the wild-type IF2mt.  Despite 
the increased activity of IF2mtΔ37 in the presence of IF1 on 70S prokaryotic ribosomes, on 
55S mitochondrial ribosomes IF1 has no effect.  The lack of an IF1 effect is not totally 
unexpected on 55S mitochondrial ribosomes because this factor is not a component of the 
mitochondrial proteome; whereas, IF1 is an essential gene in prokaryotes.  Following the 
logic of IF1’s lack of activity on 55S mitochondrial ribosomes, EcoIF2 also has no activity.  
The experiment to add the IF2mt insertion to the EcoIF2 factor, EcoIF2::37, to gain activity 
on 55S mitochondrial ribosomes was unsuccessful. 
These observations suggest that the insertion in IF2mt permits this factor to function 
effectively in the absence of IF1 and that its deletion results in an IF2 derivative whose 
activity is more dependent on the addition of IF1. Such a dependency agrees with the idea 
that IF2mtΔ37 can no longer support an infA deletion, a property also evident in transduction 
experiments performed by our collaborators, discussed later.  Addition of the insertion region 
to EcoIF2 (EcoIF2::37) leads to a factor with very low activity (Fig. 3-10). It shows little 
stimulation by IF1 but the very anemic activity of this construct makes a clear interpretation 
of this particular result difficult. However, it remains to be seen if further improvements in  
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the design of such a construct e. g., wherein the 37 amino acid insertion may be placed in an 
appropriate structural context, may allow evolution of a gain of function chimera of EcoIF2. 
 
DISCUSSION 
 
NKXD IF2mt Variants 
 
The results presented here clearly indicate that the X residue in the NKXD motif is quite 
restricted in the side chain that can be accommodated in a specific protein.  The structure of 
aIF5B indicates that the X residue points into the interior of G-domain and is relatively 
inaccessible to solvent (Fig. 3-12).  Any distortion of conformation in this region could lead 
to significant structural perturbations and the subsequent degradation of the protein.   
Structural distortion can easily arise when residues of significantly different size 
replace interior residues of a protein.  In the case of IF2mt we have replaced cysteine (86 Å
3
) 
with alanine (67 Å
3
), serine (73 Å
3
) and isoleucine (124 Å
3
) [39;40].   The C290S mutation 
results in the least net change in volume compared to the alanine or isoleucine mutations.  
This observation suggests that replacement of the sulfur of cysteine with the oxygen of serine 
permits an acceptable fold in the G-domain despite the somewhat smaller size of this 
residue.  In contrast, replacement of the sulfur of cysteine by the hydrogen of alanine creates 
too large a hole in the G-domain.  This hole may permit the penetration of water into the 
hydrophobic core of the G-domain destabilizing its structure.   
Numerous studies of protein folding indicate that the creation of cavities can 
destabilize the hydrophobic core of a domain destabilizing its entire structure.  Eriksson et al.  
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[41] have carried out an extensive mutagenic analysis with phage T4 lysoszyme.  Their data 
indicate that mutation of leucine to alanine at a variety of positions resulted in a significant 
loss in the stability of the protein.  Cavities can lead to substantial repacking of the interior.  
A single interior mutation can decrease the stability of a protein by up to 9 kcal/mol [39] 
potentially causing the protein to unfold.   
In contrast to the potential cavity formed in the C290A variant the bulky side chain of 
Ile would create significant steric clashes in the tightly packed interior of the G-domain.  
These steric clashes would be expected to distort the structure of this domain preventing the 
proper folding of the protein and perhaps exposing hydrophobic residues of the core to 
solvent.  Thus, although the designation of a residue as (X) suggests that the amino acid in 
this position is random, proteins are highly ordered macromolecules and many positions can 
accommodate a limited repertoire of amino acids.  
 
IF2mt Insertion Hybrids 
 
Our working hypothesis is that the insertion in IF2mt plays the role of IF1 due to the lack of 
an identifiable IF1 in the mitochondria and the observation that a factor equivalent to IF2 is 
necessary in both prokaryotic and eukaryotic cytoplasmic systems.  Models of IF2mt have 
suggested that the insertion projects from the body of the protein.  Fitting this model into 
Cryo-EM density of IF2 on the 30S SSU places the IF2mt insertion near the region that IF1 
occupies in crystallographic studies.  Therefore, the role of the insertion domain in IF2mt 
was analyzed both by removing the insertion in IF2mt and by placing the IF2mt insertion 
into E. coli IF2.  Removal of the insertion in IF2mtΔ37 resulted in a factor that shows some 
 82 
dependence on IF1 for maximal activity in initiation complex formation.  This observation 
implicates the insertion of IF2mt in playing the role of IF1 or at least providing the contacts 
with the prokaryotic ribosome to attain maximal initiation complex activity.  However, 
addition of this region to E. coli IF2 (EcoIF2::37) resulted in a factor that has lost all activity 
in initiation complex formation.  This loss of activity could have arisen from a distortion in 
the protein structure.  In creating these hybrids we were concerned about damaging the fold 
of the protein and some structural distortions have probably resulted as suggested by the 
decreased binding activity of these hybrids. 
In vivo work carried out by our collaborators in India revealed that IF2mt can not 
only replace IF2 in E. coli IF2 deletion strains but can also rescue the double knock-out 
IF1/IF2 E. coli strains.  Experiments have shown that the IF2/IF1 knock-out cannot be 
rescued by E. coli IF2 since the IF1 gene is essential in bacteria.  However, the double 
deletion can be rescued by IF2mt strongly suggesting that IF2mt provides the function of 
both IF1 and IF2.  Clearly since the IF1 deletion is lethal there is some inherent ability of 
IF2mt to replace the functionality of this factor.  Both IF2mtΔ37 and EcoIF2::37 can rescue 
the strain in which the IF2 gene has been knocked out.   The in vivo work strongly supports 
the idea that IF2mt serves the role of both IF2 and IF1. These gain-of-function experiments 
are a powerful indication that the insertion in IF2mt in translation does in fact replace need 
for a mitochondrial IF1 factor. 
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CHAPTER IV 
 
AUXILIARY TRANSLATIONAL FACTORS OF MAMMALIAN 
MITOCHONDRIAL RIBOSOMES 
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INTRODUCTION  
 
Mammalian mitochondrial DNA (mtDNA) encodes 13 proteins, 2 rRNAs and 22 
tRNAs.  The heart mitochondrial proteome was characterized using 1D PAGE separation and 
mass spectrometry analysis and revealed 615 distinct protein products [1].  It is proposed that 
there are up to 1500 proteins that compose the mitochondrial proteome [2].  Therefore, there 
is quite a large gap in our understanding of the proteins involved in mitochondrial 
biosynthesis and the internal functions of this organelle.  Of important interest is the 
mechanism used to synthesize the 13 polypeptides encoded in the mitochondrial genome.  
This biosynthetic process is divided into 4 stages of translation:  initiation, elongation, 
termination and recycling.  All of these stages require specific auxiliary factors (initiation 
factors, elongation factors and recycling factors) as well as factors involved in ribosome 
biogenesis and function.  There are a number known translational factors in both prokaryotes 
and yeast mitochondria that have yet to be identified in the mammalian mitochondrial 
system.  In fact, there are still translational factors being discovered in the prokaryotic 
system, for example the recently described protein LepA [3]. 
LepA is the first gene in a bicistronic operon in E. coli.  The second gene is the leader 
peptidase or lep gene which encodes the signal peptidease Lep [4].   A knockout of the LepA 
gene in E. coli has no discernible phenotype [5] but this protein was found associated with 
Staphylococcus aureus ribosomes in antibiotic crosslinking studies [6].  LepA, a ubiquitous 
protein found in all bacteria and mitochondria, was recently characterized as being an 
additional elongation factor (and thus a proposed renaming to EF4) after EF-Tu, EF-Ts and 
EF-G [3].  The sequence homology to other translational GTPases such as IF2 and EF-G 
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strongly suggests its interaction with the ribosome.  LepA is a highly conserved protein 
having an amino acid identity across all bacteria from 55% - 68% (Table 4-1).   This 
conservation suggests an important biological role.  The structure of LepA is thought to be 
very similar to that of EF-G, which is a mimic of the EF-Tu:GTP:aa-tRNA ternary complex 
structure (Fig. 4-1).  As detailed in Chapter I the steps of elongation in bacteria are clearly 
defined by EF-Tu delivering an aa-tRNA to the A-site of the ribosome while EF-G 
translocates the complex following peptidyl transfer of the growing polypeptide from the P-
site tRNA to the A-site tRNA.  Where does this leave LepA?  Experimental evidence 
suggests that LepA recognizes the ribosome that has undergone a defective translocation 
action.  LepA corrects this defect by back translocating the tRNAs and mRNAs giving EF-G 
another chance to carry out translocation correctly [3].  In this Chapter the cloning of the 
mammalian mitochondrial LepA homolog is reported.  
The discovery of new mitochondrial translational factors such as LepA using a 
bioinformatics approach has prompted us to search the human expressed sequence tag (EST) 
sequence for other factors involved in prokaryotic and yeast mitochondrial ribosomal 
biogenesis, ribosome receptors and other accessory ribosomal factors.  For the identification 
of human mitochondrial homologs of other factors required in protein synthesis or ribosome 
biogenesis, a number of criteria must be applied.  First, homology search using tools such as 
the BLAST program at the National Center for Biotechnology Information (NCBI) must 
indicate a reasonable degree of amino acid identity at least in portions of the identified 
protein.  As a minimum a 20 % identity is desired to proceed with further analysis.  Once a 
candidate protein has been identified, further examination of the sequence must be carried 
out to assess whether it could potentially be localized to mitochondria.  Several criteria can 
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be applied here.  First, many proteins localized to the mitochondria have N-terminal import 
sequences.  These sequences can be identified with about 75 % accuracy using prediction 
programs such as MitoProtII  and PSORT [7;8].  Second, specific promoter sequences in 
nuclear genes encoding mitochondrial proteins can be used to identify these factors.  
Previous work has analyzed the roles of various promoters in respiratory gene expression in 
mammalian cells and identified two nuclear respiratory factors (NRF) sequences, NRF-1 and 
NRF-2, which play a key role [9].  A recent study of the promoter of IF2mt revealed that 
nuclear regulatory factor 2 (NRF-2) binding sites are present as tandem pairs.  This promoter 
architecture is also found in many ribosome associated proteins such as EF-Tumt, EF-G1mt, 
RF1mt, MetRSmt, rpL3mt and rpS12mt [10;11] (Fig. 4-2).  Other factors localized to 
mitochondria that are known to be controlled by NRF-1 and NRF-2 include TOM20, 
succinate dehydrogenase subunits B, C and D of complex II, and cytochrome oxidase subunit 
Vb of complex IV [9;11;12].  Therefore a traditional sequence homology alignment and 
promoter analysis of known mitochondrial translational factors are a good start to identify 
potential mitochondrial proteins which may have a role in translation.  
 
MATERIALS AND METHODS  
 
Materials:  Chemicals were purchased from Sigma and Fisher Scientific.  Oligonucleotide 
primers were perpared at the Nucleic Acids Core Facility (University of North Carolina).  All 
plasmids were purified using QIAGEN Qiaprep® Miniprep Handbook as described by the 
manufacturer.  Restriction enzymes were purcfhased from New England Biolabs.  Digested  
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plasmids and PCR products were purified using the Qiagen Gel Extraction/PCR Purification 
Kit.  
 
Cloning of mtLepA:  Human mtLepA was identified in the ESTs by BLAST analysis using 
the E. coli LepA sequence as a query.  The cDNA was ordered from American Type Culture 
Collection (ATCC).  The coding sequence was amplified out of the starting pCMV-SPORT6 
vector using the following primers: Forward primer with NcoI restriction site 5'-CCA ACC 
ATG GCG CCG ACC CTT GGG G-3' and Reverse primer with XhoI restriction site 5'-GGT 
TCT CGA GTT TAG AAG ATT GTG TTT TCA GAA CTT TTA TGA AAG-3'. This PCR 
product was digested with NcoI and XhoI along with purified pET24d(+) plasmid. The PCR 
product was ligated into the pET24d(+) plasmid at 16 °C for 16 h under standard conditions. 
The ligated plasmid was then transformed into Stratagene DH5α, sequenced and subcloned 
into Stratagene BL21 (DE3) RIL cells according to the Stratagene protocols. 
 
Growth Studies of mtLepA: Overnight cultures of E. coli BL21 (DE3) RIL cells containing 
either pET24d mtLepA, pET21b mtEF-G or no plasmid were grown in 20 mL of LB with 34 
μg/mL chloramphenicol (for the RIL plasmid present in all cells) and the appropriate 
secondary plasmid antibiotic, 50 μg/mL kanamycin for pET24d and 100 μg/mL ampicillin 
for pET21b.  These overnight cultures were used to inoculate, using a 1 % dilution, 200 mL 
of LB with the appropriate antibiotic in 500 mL side armed (Nephelo) flasks.  The growth of 
the cells was monitored every 30 minutes by measuring the A600 on a Bausch and Lomb 
Spectronic 20 spectrophotometer.  At approximately 0.8 A600 the cells were induced with 0.1 
M IPTG.  Following induction the cells were diluted 10-fold in LB containing the 
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appropriate antibiotic and 0.1 M IPTG and the effect of induction on the growth of the cells 
was monitored to a total time of 600 minutes. 
 
Elucidation of Auxiliary Mammalian Mitochondrial Translational Factors:  Sequences of 
known prokaryotic and yeast mitochondrial factors involved in translation were submitted for 
a TBLASTN search against Homo sapian RefSeq proteins and ESTs at the National Center 
for Biotechnology Information (NCBI) website, http://www.ncbi.nlm.nih.gov/BLAST/.  The 
top scores were analyzed and top candidates were submitted subjected to MITOPROT 
analysis at http://ihg.gsf.de/ihg/mitoprot.html to determine if a mitochondrial import 
sequence was present.  If an import sequence was verified then the mature truncated form 
was used to realign the sequence via CLUSTLW to determine the percent identity to the 
query sequence. 
 
Promoter Analysis:  Once the putative mammalian mitochondrial translation factor gene has 
been identified, the cDNA or gene name is queried using BLAT alignment tool or Genome 
Browser at the UCSC Genome Bioinformatics website, http://genome.ucsc.edu, which 
contains the latest build of the human genome.  Once the gene has been located on the 
particular chromosome the upstream promoter sequences can be obtained and analyzed using 
the Transcription Element Search System (TESS) at http://www.cbil.upenn.edu/cgi-
bin/tess/tess.  
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RESULTS  
   
mtLepA 
 
Human mitochondrial LepA (mtLepA) was identified by a BLAST search against the Homo 
sapians database using the E. coli LepA factor (NP_417064) as a query sequence.  
Alignment revealed the human homolog with 47% identity, Unigene sequence 
Hs.546419.  The protein was analyzed using MitoProtII to determine the presence of 
a mitochondrial import sequence and with a 94% probability the import sequence was 
defined as the first 32 residues.  Therefore the proposed mature sequence begins at residue 
33.  An alignment of these two factors is shown in Figure 4-3, which clearly shows the 
significant identity between these two factors. 
The cDNA of this protein was ordered from ATCC and subcloned into the expression 
vector.  Once this gene was sequenced several differences from the original cDNA clone, as 
reported at NCBI, were indicated as possible point mutations which resulted in a number of 
amino acid changes.  These mutations were analyzed using a TBLASTN analysis of the 
Homo sapiens mtLepA sequence against the human expressed sequence tag (EST) 
database.  All mutations except one were revealed to be errors in the original NCBI 
sequence.  As shown in Figure 4-4, the single P/L mutation at residue 58 turns out to be an 
isoform of mtLepA, where both P and L are present in equal proportions in various ESTs.  
The variant that was cloned has a L residue at position 58.  This isoform lies within a region 
that has no homology to E. coli LepA.  Therefore the ESTs confirm the mtLepA sequence 
that was cloned was indeed correct and could be used for further experiments.  
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The primary experiment to test the activity of mtLepA was an in vivo expression 
monitoring the growth of the E. coli BL21 (DE3) RIL cells prior to and following induction 
of the protein using IPTG.  The effects of in vivo induction with IPTG on E. coli LepA in  
BL21 cells was previously performed and revealed a quite dramatic and unrecoverable effect 
on cell growth [3].  The experiments performed on pET24d mtLepA in BL21 (DE3) RIL 
cells revealed that the cells can recover after induction (Fig. 4-5B).  mtLepA shows a 
significant lag in growth relative to the E. coli BL21 (DE3) RIL cells that did not contain a 
plasmid and EF-Gmt.  Following the 1/10 dilution and induction with IPTG both EF-Gmt 
and mtLepA have a significant lag time but nevertheless they both grow.  These results differ 
quite dramatically from the E. coli factors (Fig. 4-5A). 
   
Auxiliary Translational Factors 
 
To begin the search for auxiliary mitochondrial translational factors, known bacterial and 
yeast mitochondrial factors were subjected to a BLASTP analysis against the RefSeq Homo 
sapiens database.  Previous analysis using cyber searching had revealed the presence of 
mitochondrial initiation factor 3 (IF3mt) [13], the prokaryotic LepA [3], and prokaryotic 
YidC.  YidC is known to be homologous to yeast mitochondrial Oxa1p [14-16] which is 
involved in the insertion of membrane proteins into the mitochondrial membrane.  MitoProtII 
revealed that all of these proteins have very strong mitochondrial import sequences, with > 
93% probability of import.  Following MitoProtII analysis the first 30 amino acids of each 
protein sequence was entered into a BLAT search at the UCSC Genome Database to find the 
gene on its respective chromosome.  The genes were then selected and the genomic  
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sequences were gathered -200 and +100 nucleotides from the transcription start sites.  The 
promoter regions of IF3mt, mtLepA and mtOxa1 all contained strong NRF-2 sequences and 
the mtLepA sequence also contained a putative NRF-1 site (Fig. 4-6).  The mitochondrial 
import, NRF-1 and NRF-2 sequence data for each factor was compiled into Table 4-2.  
To extend this analysis other factors known to be involved in the mitochondrial 
translational apparatus in yeast were analyzed.  These factors were Mba1, Mdm38 and Ylh47 
[17;18].  Mba1 has been suggested to interact with Oxa1p and the large subunit of the yeast 
mitochondrial ribosome recruiting it to the mitochondrial membrane [17].  This factor is a 
good target for analysis because there is a Oxa1 homolog in mammalian mitochondria.  
However, a simple BLASTP analysis using Mba1as a query revealed that there were no 
known human or prokaryotic homologs of this protein.  If such a homolog exists, its 
sequence must have diverged too much for BLAST analysis to find it.  Analysis was 
continued on the yeast factors Mdm38 and Ylh47 which have known homology to human 
factor Letm1 [18] (Fig. 4-7).  Letm1 is thought to be an inner mitochondrial membrane 
protein which plays a role in potassium and hydrogen ion exchange [19].  A BLASTP 
analysis using Mdm38 and Ylh47, as queries against the human RefSeq database confirmed 
that they were most closely related to Letm1.  This Letm1 has no mitochondrial import 
sequence but analysis of the promoter region of this factor revealed two NRF-2 motifs, 
Figure 4-6 and Table 4-2. 
Additional prokaryotic factors known to interact with the translational machinery 
were also evaluated including CgtAE, SpoT, Era, YciH and ObgE (Fig. 4-6, Fig. 4-8 and 
Table 4-2).  CgtAE is involved in the assembly of the 50S large subunit [20].  The human 
homolog of CgtAE has a predicted mitochondrial import signal with 99% probability and the  
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promoter sequence contains five NRF-2 binding sites.  The factor SpoT, which is a ppGpp 
synthase/hydrolase, copurified with CgtAE on the prokaryotic ribosome [21] and BLASTP 
analysis of its protein reveals that only the N-terminus of this factor is homologous to a 
human factor.  The N-terminal region of this SpoT homolog was analyzed and no 
mitochondrial import sequence was revealed.  However two NRF-2 motifs are present in its 
promoter region. Era is a prokaryotic factor implicated in small subunit assembly [22].  The 
BLAST analysis of this factor was meager but analysis of the top human homolog revealed a 
predicted mitochondrial import of 95% as well as four NRF-2 motifs.  The prokaryotic factor 
YciH is homologous to eukaryotic factor eIF1 but it is not an essential gene and its function 
is not known [23].  BLASTP analysis of YciH reveals that this factor is homologous to 
human eIF1 and SUI1/eIF1b, which is an isoform of eIF1.  The human homologs of YciH are 
not alternatively spliced proteins rather they are encoded in separate genes.  Neither has a 
mitochondrial import sequence.  The eIF1 factor has two NRF-2 factor binding sites and one 
strong NRF-1 motif.  The SUI1/eIF1b factor has three NRF-2 binding sites and one core 
NRF-1 motif.  The last prokaryotic factor analyzed was ObgE.  This factor has been 
implicated in ribosome biogenesis and the human factors homologous to this protein, ObgH1 
and ObgH2, have previously been studied [24;25].  ObgH1 and ObgH2 are encoded by two 
different genes and only ObgH1 has a mitochondrial import signal, with 99% probability of 
import.  The import sequence along with biochemical studies [24;25] suggests the both the 
cytoplasmic and mitochondrial ribosomes require their own factors for ribosome 
biogenesis.  Promoter analysis of the mitochondrial factor, ObgH1, revealed no NRF-2 factor 
binding sites. 
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In addition to auxiliary translational factors, the nuclear encoded mitochondrial 
ribosomal protein gene’s promoter regions were subjected to the same analysis as above.  It 
was observed that of the approximately 80 proteins that constitute the mitochondrial 
ribosome only one lacks a core NRF-2 factor binding site (CGGAAG) and only seven 
contain NRF-1 factor binding sites ((C/T)GCGCA(C/T)GCGC(A/G)).   
 
DISCUSSION 
 
The cloning and growth studies of mtLepA reveal the presence of a nearly universal 
translational factor for the mitochondrial system which, that  sequence homology and growth 
study comparisons reveal, plays the role of back translocating mistranslocated mitochondrial 
ribosomes.  This function could provide a vital mechanism for correction the in 
mitochondrial system.  Any error in the translation of the mitochondrial genome can result is 
significant problems with energy generation in the cell.  Surprisingly the growth of mtLepA 
and EF-Gmt differ quite significantly from their E. coli counterparts.  EF-Gmt grows 
normally before induction but following induction it exhibits a similar but less severe lag in 
growth as mtLepA.  mtLepA exhibits an extended lag phase in growth both before and after 
induction.  The delayed growth could be due to leaky expression of this protein from the pET 
vector resulting in a disrupted protein synthesis, as seen in the E. coli growth studies.  
Furthermore, the extended lag following induction and subsequent exponential growth after 
300 min could be the result of a mutant pickup. 
The search for new mitochondrial translational proteins has revealed a very diverse 
and complex array of proteins.  Using known bacterial and yeast mitochondrial proteins 
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involved in translation provided as excellent starting point for future analysis and 
understanding of the mitochondrial translational machinery.  Furthermore the presence of 
NRF-1 and NRF-2 promoters which have been shown to be important upstream elements 
involved in the translation of mitochondrial targeted genes in the nuclear genome.  Further 
biochemical experimentation needs to be done to determine the validity of the cyber-probing 
but the potential elucidation of novel mitochondrial factors such as mtCgtAE and mtERA 
which may potentially play the role of their prokaryotic homologs, assembly of the large and 
small subunit respectively, provide new avenues of research.  Additionally the presence of 
Letm1, a homolog of yeast mitochondrial proteins Mdm38 and Vlh47, suggests another 
pathway in machinery involved in the insertion of proteins into the inner membrane. 
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